Edited by Richard Sheaves, Paul J. Jenkins, and John A.H. Wass. 559 pp., illustrated. Cambridge, Mass., Blackwell Science, 1997. $199.95. ISBN 0-86542-862-X.
Malignant tumors in endocrine organs are rare, but when takentogether account for more than 2 percent of all cancers. Theirtreatment is dispersed among specialized departments (endocrinology,gastroenterology, pneumology, hypertension, neurology, surgery,and general oncology), where each specialist treats the aspecthe or she has been trained for. Most malignant endocrine tumorsare slow growing. However, some patients will die of tumor progressionor its metabolic consequences. Adequate management of such lesionsmust include treatment of the tumor and the metabolic consequencesof any endocrine hypersecretion. For this reason, patients withendocrine tumors should be referred to specialized units . . . [Full Text of this Article]
Previous
